Boehringer US head covers GLP-1s, PBMs, Trump at Reuters USA

Brian Hilberdink, Boehringer Ingelheim's new Head of US Human Pharma, fielded questions on a variety of hot topics from the Reuters Pharma USA stage.

UK weight loss market: M&A opportunities

Recent advancements in weight-loss interventions are transforming the healthcare landscape and presenting new M&A opportunities

IRA updates and making sense of the chaos in Washington, wit...

Therapeutic or cosmetic? Patent strategies for dual-use inno...

In the pharmaceutical and cosmetic sectors, innovation often stems from discovering new applications for known compounds.

JP Morgan Week 2025 – Jeff Fischer

NHS medicines spending in England in greater focus

Leela Barham provides a perspective on the ABPI blog that covers understanding NHS medicines spending in England.